Versant Ventures V, Llc - Net Worth and Insider Trading

Versant Ventures V, Llc Net Worth

The estimated net worth of Versant Ventures V, Llc is at least $15 Million dollars as of 2024-11-05. Versant Ventures V, Llc is the 10% Owner of Repare Therapeutics Inc and owns about 3,544,862 shares of Repare Therapeutics Inc (RPTX) stock worth over $13 Million. Versant Ventures V, Llc is also the 10% Owner of Turnstone Biologics Corp and owns about 3,381,692 shares of Turnstone Biologics Corp (TSBX) stock worth over $2 Million. Details can be seen in Versant Ventures V, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Versant Ventures V, Llc has not made any transactions after 2023-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Versant Ventures V, Llc

To

Versant Ventures V, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Ventures V, Llc owns 5 companies in total, including Repare Therapeutics Inc (RPTX) , Aprea Therapeutics Inc (APRE) , and Crinetics Pharmaceuticals Inc (CRNX) among others .

Click here to see the complete history of Versant Ventures V, Llc’s form 4 insider trades.

Insider Ownership Summary of Versant Ventures V, Llc

Ticker Comapny Transaction Date Type of Owner
RPTX Repare Therapeutics Inc 2022-06-03 10 percent owner
APRE Aprea Therapeutics Inc 2020-04-09 10 percent owner
CRNX Crinetics Pharmaceuticals Inc 2019-02-04 10 percent owner
LIMIT LIMIT 2018-04-24 10 percent owner
LIMIT LIMIT 2023-07-25 10 percent owner

Versant Ventures V, Llc Latest Holdings Summary

Versant Ventures V, Llc currently owns a total of 2 stocks. Among these stocks, Versant Ventures V, Llc owns 3,544,862 shares of Repare Therapeutics Inc (RPTX) as of June 3, 2022, with a value of $13 Million and a weighting of 89.16%. Versant Ventures V, Llc also owns 3,381,692 shares of Turnstone Biologics Corp (TSBX) as of July 25, 2023, with a value of $2 Million and a weighting of 10.84%.

Latest Holdings of Versant Ventures V, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPTX Repare Therapeutics Inc 2022-06-03 3,544,862 3.69 13,080,541
TSBX Turnstone Biologics Corp 2023-07-25 3,381,692 0.47 1,591,086

Holding Weightings of Versant Ventures V, Llc


Versant Ventures V, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Versant Ventures V, Llc has made a total of 2 transactions in Repare Therapeutics Inc (RPTX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Repare Therapeutics Inc is the sale of 750,000 shares on June 3, 2022, which brought Versant Ventures V, Llc around $9 Million.

According to the SEC Form 4 filings, Versant Ventures V, Llc has made a total of 1 transactions in Turnstone Biologics Corp (TSBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Turnstone Biologics Corp is the acquisition of 225,000 shares on July 25, 2023, which cost Versant Ventures V, Llc around $3 Million.

Insider Trading History of Versant Ventures V, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Versant Ventures V, Llc Trading Performance

GuruFocus tracks the stock performance after each of Versant Ventures V, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Ventures V, Llc is -39.97%. GuruFocus also compares Versant Ventures V, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Ventures V, Llc within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Versant Ventures V, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Versant Ventures V, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -18.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Versant Ventures V, Llc Ownership Network

Ownership Network List of Versant Ventures V, Llc

No Data

Ownership Network Relation of Versant Ventures V, Llc

Insider Network Chart

Versant Ventures V, Llc Owned Company Details

What does Repare Therapeutics Inc do?

Who are the key executives at Repare Therapeutics Inc?

Versant Ventures V, Llc is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .

Repare Therapeutics Inc (RPTX) Insider Trades Summary

Over the past 18 months, Versant Ventures V, Llc made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Repare Therapeutics Inc Insider Transactions

No Available Data

Versant Ventures V, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Ventures V, Llc. You might contact Versant Ventures V, Llc via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.